Expanded Access to Triheptanoin

Available (expanded access)

Conditions studied: Long Chain Fatty Acid Oxidation Disorders

In brief

Expanded access may be provided for qualified patients who have limited treatment options and are not eligible for a clinical trial.

Key facts

Study ID

NCT03773770

Run by

Ultragenyx Pharmaceutical Inc

Last updated by the study team

2026-07-31

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.